Evolutionary Genomics
Latest round
- Series A
Last raised
- Apr 2008
Total raised
- Undisclosed
Investors
- 1
About Evolutionary Genomics
Evolutionary Genomics, headquartered in Lafayette, US, specializes in genetic solutions for the agricultural sector. The company has undergone strategic pivots to enhance its product offerings, particularly focusing on patented resistance genes.Evolutionary Genomics specializes in the development and commercialization of genetic solutions aimed at enhancing agricultural productivity and resilience. The company’s core product offerings include patented resistance genes, such as the FusR1 gene, which is critical in combating the aggressive Fusarium TR4 fungus affecting banana crops. The FusR1 gene has been identified in wild banana relatives and can be utilized through various agricultural techniques, including marker-assisted traditional breeding, gene editing, and transformation. Additionally, the company has developed the EG261 gene, which provides resistance to diseases and pests without chemicals, along with candidate genes in tomatoes and cotton that enhance sweetness and pest resistance, respectively.Evolutionary Genomics generated revenue of USD 12,500 in the most recent fiscal year, 2020, with an EBITDA of USD -992,809 for the year 2022. The company generates revenue through licensing its patented genetic technologies to agricultural producers and biotechnology firms, typically involving partnerships with large-scale agricultural companies that utilize these proprietary genes for crop improvement and disease resistance in their product lines.Evolutionary Genomics aims to enhance its product portfolio with new genetic solutions targeting crop resilience and productivity, although specific upcoming product launches have not been disclosed. The company is actively seeking to expand its markets, particularly targeting regions in South and Central America, and plans to strengthen its presence in the European Union agricultural markets.
Who invested in Evolutionary Genomics
1 investor across 1 round
See all investors in Evolutionary Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 11, 2008
Amount
Undisclosed
Investors
Questions about Evolutionary Genomics
Who invested in Evolutionary Genomics?
Evolutionary Genomics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evolutionary Genomics raised?
Evolutionary Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Evolutionary Genomics last raise money?
Evolutionary Genomics's most recent round on record is a Series A, in Apr 2008.
What does Evolutionary Genomics do?
Evolutionary Genomics, headquartered in Lafayette, US, specializes in genetic solutions for the agricultural sector.
Where is Evolutionary Genomics headquartered?
Evolutionary Genomics is headquartered in Lafayette, US.
Which VCs invest in companies like Evolutionary Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Evolutionary Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Evolutionary Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.